Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Preleukemia; Syndrome Phase 2 ClinicalTrials
Esophageal Neoplasms Phase 1/Phase 2 ClinicalTrials
Leukemia; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelomonocytic, Juvenile; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms; Preleukemia; Syndrome Phase 1/Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 1/Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Hematologic Neoplasms; Neoplasms; Prostatic Neoplasms Phase 1 ClinicalTrials
Melanoma Phase 1/Phase 2 ClinicalTrials
Leukemia; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelomonocytic, Juvenile; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms Phase 1/Phase 2 ClinicalTrials
CONTENTS